Case report and literature review of BRAF-V600 inhibitors for treatment of papillary craniopharyngiomas: A potential treatment paradigm shift.
Penelope E NussbaumLeslie A NussbaumCollin M TorokPuja D PatelTiffany A YesavageEric S NussbaumPublished in: Journal of clinical pharmacy and therapeutics (2022)
We reviewed the literature on BRAF-V600E inhibition as a non-invasive method of treating papillary craniopharyngiomas harbouring the BRAF-V600E mutation.